Theralase Technologies Inc. V.TLT

RE:Theralase's Cash Prognosis is better than most think

[GoTogether]

• Cash(1)                                                                                     $        + 932,024

• Accounts Receivable(1)                                                              + 1,344,684

• minus Liabilities, Accounts Payable(1)                                        - 592,622

• Warrants Exercised,

542,464 (31,885,539(1)  - 31,343,075(2)) x 0.44                                    + 238,684

• Warrants Exercised, August 25, 2017,  1,250,000 x 0.54                      + 675,000

• Options Exercised,

1,015,000 (10,600,000(1) - 9,585,000(2)) x 0.54                                    + 548,100

                                                                                                             --------------- +

                                                                                                             3,145,870

(1) Condensed Interim Consolidated Financial Statements

Unaudited As at June 30, see Sedar.com

(2) Theralase Corporate Presentation – 3Q2017

Conclusion :

Currently there’s no urgent need for money.

Counting from June 30, 2017 an amount of $ 3,145,870 is available.

Taking into account a burn rate of around 500,000 per month,

there should be money in the till until new year.

Bashers want us to believe a PP is imminent, this is simply not true.

Have  nice weekend.